News
Vaccinogen is pleased to announce that ProVaccine, its Swiss-based distribution partner for OncoVAX®, has been granted permission to export biopsy’s and import vaccines for OncoVAX® in Switzerland.
Vaccinogen is pleased to announce that ProVaccine, its Swiss-based distribution partner for OncoVAX®...
Thomson Reuters' Pharma Matters highlights Vaccinogen’s OncoVAX® as “One to Watch”
The Pharma Matters quarterly report series was launched two years ago and covers all aspects of the pharmaceutical pipeline, leveraging strategic intelligence and competitive analysis...
Learn more >>
Publications
Human Vaccines 2006
Active Specific Immunotherapy with Autologous Tumor Cell Vaccines
Learn more >>
Cancer Vaccine Space
Vaccinogen is uniquely positioned within the cancer vaccine space
Learn more >>